ESC Webinars Series - Diabetes. Focus on SGLT2 Inhibitors - New data and guidelines change practice
25 February 2020, from
European Society of Cardiology
Diabetes and the Heart
Professor G. Rosano (London, GB)
Doctor O. Mosenzon (Jerusalem, IL)
Professor M. Petrie (Glasgow, GB)
Discover the ESC Webinar Series - Diabetes
The ESC Webinar Series - Diabetes was designed to provide the audience with a comprehensive view of what is new on diabetes management that will be readily applicable in everyday clinical practice.
Review new evidence emerged from recent clinical trials
After watching the webinar, participants will be able to know what is the role of SGLT2 inhibitors in treating and preventing HF in diabetic patients.
This webinar is designed for all practicing cardiologists working in the field of diabetes, pre-diabetes and cardiovascular diseases, heart failure, and those wishing to update their scientific knowledge on the topic.
During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.
The webinar is available on PC and tablets. The use of a smartphone is not recommended.
To answer the MCQs during the live, you must allow pop-up windows.
A high-speed Internet connection is required (minimum 2 Mbps).